Vanta Bioscience Limited
Vanta Bioscience Limited is a Public Non-govt company company incorporated in 2016 and based in Telangana, India. Vanta Bioscience Limited operates in Business Services (NIC 74999) with authorized capital of ₹7.50 Cr and paid-up capital of ₹6.31 Cr. For 2025-26, the company reported revenue of ₹1.82 Cr and profit after tax of ₹12.00 L. RegisterKaro's provisional Compliance Health Score for the company is 67/100 (grade C), based on 4 of 9 signals — full scoring is pending extraction of the company's MCA filing history.
VANTA BIOSCIENCE LIMITED is the legal entity of Vanta Bioscience.
Quick facts
Directors
LockedDirectors, DINs & appointment history for Vanta Bioscience Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
MCA Filings
Locked| Form | FY | Filed | Due | Delay | Status |
|---|---|---|---|---|---|
| AOC-4 | FY2024-25 | 30 Oct 2024 | 30 Oct 2024 | 0d | filed |
| MGT-7 | FY2024-25 | 20 Nov 2024 | 29 Nov 2024 | 0d | filed |
| AOC-4 | FY2023-24 | 30 Oct 2023 | 30 Oct 2023 | +6d | filed |
| MGT-7 | FY2023-24 | 26 Nov 2023 | 29 Nov 2023 | 0d | filed |
| AOC-4 | FY2022-23 | 30 Oct 2022 | 30 Oct 2022 | 0d | filed |
| MGT-7 | FY2022-23 | 20 Nov 2022 | 29 Nov 2022 | 0d | filed |
Full MCA filing history for Vanta Bioscience Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Charges
Locked| Charge ID | Holder | Amount | Created | Status |
|---|---|---|---|---|
| 587662143 | Axis Bank Ltd(Bank) | ₹10.44 Cr | 27 Jan 2023 | Open |
| 481663062 | ICICI Bank Ltd(Bank) | ₹20.67 Cr | 27 Jan 2019 | Open |
| 865475029 | Kotak Mahindra Bank Ltd(Bank) | ₹11.87 Cr | 04 Jul 2019 | Open |
| 137879982 | State Bank of India(Bank) | ₹20.36 Cr | 27 Jan 2022 | Open |
| 691128460 | Kotak Mahindra Bank Ltd(Bank) | ₹12.69 Cr | 27 Jan 2022 | Open |
| 875274168 | ICICI Bank Ltd(Bank) | ₹6.71 Cr | 27 Jan 2020 | Open |
Charge IDs, lenders & amounts for Vanta Bioscience Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Financial Performance
MCA| FY | Revenue | PAT | Net Worth | Total Assets | Employees |
|---|---|---|---|---|---|
| 2025-26 | — | ||||
| 2022-23 | — | ||||
| 2021-22 | — | ||||
| 2019-20 | — | ||||
| 2018-19 | — | ||||
| 2017-18 | — | ||||
| 2016-17 | — |
Detailed Financials
4 FYs| Line item | 2025-26 | 2022-23 | 2021-22 | 2019-20 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue from operations | ||||
| Other income | ||||
| Total income | ||||
| Total expenses | ||||
| Profit before tax | ||||
| Profit / (Loss) after tax | ||||
| Balance sheet | ||||
| Equity / Net worth | ||||
| Borrowings | ||||
| Current liabilities | ||||
| Total liabilities | ||||
| Current assets | ||||
| Cash & equivalents | ||||
| Total assets | ||||
| Employees | — | — | — | — |
Cash-flow statement renders when the AOC-4 XBRL Cash Flow context is parsed during the extract phase.
Compounded Annual Growth Rate
| Metric | Latest value | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|
| Revenue2025-26 | -68.0% | -96.0% | -54.0% | |
| Profit after Tax2025-26 | +77.0% | -62.0% | — | |
| Net Worth2022-23 | -35.0% | -33.0% | +1.0% |
Financial Ratios
| FY | Revenue | PAT | PAT margin | Rev growth | ROE | ROA | D/E | Rev/emp |
|---|---|---|---|---|---|---|---|---|
| 2016-17 | — | — | +0.00% | +0.00% | 2.24 | |||
| 2017-18 | +0.68% | — | +0.16% | +0.09% | — | |||
| 2018-19 | +5.48% | +213.31% | +3.12% | +1.83% | — | |||
| 2019-20 | +6.88% | +12.39% | +4.17% | +2.35% | — | |||
| 2021-22 | +0.84% | -34.26% | +0.12% | — | — | |||
| 2022-23 | — | -44.69% | — | — | — | |||
| 2025-26 | +6.59% | -64.80% | — | — | — |
Cap Table & Shareholding
Locked| Category | Shareholders | Shares held | % |
|---|---|---|---|
| Promoters | 3 | 61,97,894 | 67.91% |
| Institutional Investors | 2 | 9,32,218 | 10.21% |
| Public & Others | 6 | 19,96,558 | 21.88% |
Promoter, institutional & public holding for Vanta Bioscience Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Peer Benchmark
500 peersEvents & timeline
3External data sources
7 plannedGSTIN Registrations
Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.
MSME Payment Delays
Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.
Related Party Transactions
Counterparty, nature, transaction value. Inter-company loans, sales, royalty.
Credit Ratings
Long-term + short-term ratings, with rationale on rating actions.
Trademarks
Applied, registered, opposed. Class numbers + status.
Patents
Applications and grants. Inventor names + filing dates.
Legal Cases
Ongoing + past litigations the entity is party to.
Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.